IDH1 and central nervous system cancer: Furthermore, tissue heterogeneity (homogeneity and pixel correlation) and FLAIR border distinctiveness (edge contrast, or EC) could optimally classify grade II/III gliomas by IDH status, which may give a hand for subsequent therapeutic choices [67].